Back To Search Instructions
Protocols
9 protocol(s) meet the specified criteria
Age Group: A
Disease Site: Cervix
Protocol No.TitleStatus
15991Developing a Yoga Intervention During Cancer ChemotherapyOpen
17404A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid TumorsOpen
187020Phase 1 Open-label, Multicenter Study of MK-1454 Administered by Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab for Patients With Advanced/Metastatic Solid Tumors or LymphomasOpen
187021AN OPEN-LABEL, MULTICENTER, PHASE II STUDY TO EVALUATE THE THERAPEUTIC ACTIVITY OF RO6874281, AN IMMUNOCYTOKINE, CONSISTING OF INTERLEUKIN-2 VARIANT (IL-2V) TARGETING FIBROBLAST ACTIVATION PROTEIN-A (FAP), IN COMBINATION WITH ATEZOLIZUMAB (ANTI-PD-L1), ADMINISTERED INTRAVENOUSLY, IN PARTICIPANTS WITH ADVANCED AND/OR METASTATIC SOLID TUMORSOpen
18801Non-pharmacologic approaches to relieve pain and symptom distress among diverse hospitalized cancer patientsOpen
189520A Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced CancerOpen
18953Phase 1/2 Dose Escalation and Expansion Study Evaluating Safety, Tolerability, Pharmacokinetic, Pharmacodynamics and Anti-tumor Activity of PF-06873600 as a Single Agent and in Combination with Endocrine Therapy Open
189820Ride to care - A pilot study to investigate the clinical and quality of life benefit of eliminating transportation barriers for disadvantaged cancer patients undergoing ambulatory palliative radiotherapy Open
19955An Open-label Phase 1b Study of ORIC-101 in Combination with Anticancer Therapy in Patients with Advanced or Metastatic Solid TumorsOpen